Boustead Securities
- Mar 5, 2017
- 0 min read

Dan McClory of Boustead Securities on China's investment climate

Recent Posts

Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering

Boustead IPO Client HeartCore Enterprises, Inc. Announces Closing of $15.0 Million Nasdaq IPO

Boustead Client HeartCore Enterprises, Inc. ("HTCR") Announces Pricing of $15.0 Million IPO